Management & Regulatory

Is Investing in Biopharmaceutical Characterization Services Worth It?
Management & Regulatory Is Investing in Biopharmaceutical Characterization Services Worth It?

The global biopharmaceutical characterization service market is garnering significant attention due to its transformative potential in drug development and personalized medicine. Characterization services, which include protein and peptide analysis, provide crucial data for understanding the

Is the Pharmaceutical Industry Shifting Towards Complex Molecules?
Management & Regulatory Is the Pharmaceutical Industry Shifting Towards Complex Molecules?

The pharmaceutical industry finds itself at a pivotal juncture, marked by a significant transformation in drug approvals. According to insights from the CPHI Annual Industry Survey, approvals for complex molecules are poised to surpass those for small molecules for the first time. This shift

Institutional Investors Show Strong Confidence in Sutro Biopharma's Future
Management & Regulatory Institutional Investors Show Strong Confidence in Sutro Biopharma's Future

Sutro Biopharma, Inc. has caught the eye of institutional investors recently, marking a significant development in the clinical-stage oncology company's journey. With its innovative approach to developing antibody-drug conjugates (ADCs) using proprietary platforms, Sutro Biopharma has seen a

Eli Lilly's $4.5B Medicine Foundry to Boost Drug Production by 2027
Management & Regulatory Eli Lilly's $4.5B Medicine Foundry to Boost Drug Production by 2027

Eli Lilly's continued advancements in pharmaceutical innovation and their commitment to escalating manufacturing capabilities encapsulate the core of the company's recent endeavors. At the heart of these developments is Eli Lilly’s extensive investment in research and development and the s

Can LakeShore Biopharma Stock Overcome Its Recent Volatility?
Management & Regulatory Can LakeShore Biopharma Stock Overcome Its Recent Volatility?

LakeShore Biopharma Co Ltd. (NASDAQ: LSB) has attracted significant attention in the stock market due to its highly volatile performance over the past year. Investors have witnessed dramatic shifts in the company's stock price, reflecting a mixed sentiment among stakeholders about the

Eastern North Carolina Welcomes Major Pharmaceutical Investments
Management & Regulatory Eastern North Carolina Welcomes Major Pharmaceutical Investments

Wilson County, located in Eastern North Carolina, has recently become a hotspot for significant economic development, largely driven by substantial investments from pharmaceutical giants. Within the past eight days, the region has received promises of major funding, hinting at a promising future

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later